Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology.

Abstract

We wish to respond to a recent discussion of systemic bioavailability of inhaled corticosteroids that appeared as a letter to the editor [1]. The authors contend that an estimate of the true systemic bioavailability of inhaled mometasone furoate (MF) cannot be made based on incomplete data and an insensitive assay, and that comparisons with other inhaled… (More)

Topics

Cite this paper

@article{Affrime2001SystemicBO, title={Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology.}, author={Melton B. Affrime and Cedric C Banfield and Keith B. Nolop}, journal={The European respiratory journal}, year={2001}, volume={18 1}, pages={246} }